Adherence Improvement in Glaucoma Patients

Not Applicable

Completed

• Conditions: Glaucoma

• Registration Number: NCT00603005
• Lead Sponsor: Maastricht University Medical Center

Brief Summary

The purpose of this study is to study the effect on intraocular pressure in glaucoma patients using the TravAlert dosing aid with or without the Eyot drop guider and with or without additional patient education.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10
• Study First Submitted: 2008-01-15
• Study First Submitted QC: 2008-01-26
• Study First Posted: 2008-01-28
• Primary Completion: 2009-10
• Study Completion: 2010-01
• Status Verified: 2010-02
• Last Update Submitted: 2010-02-23
• Last Update Posted: 2010-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 802

Inclusion Criteria

• Diagnosis glaucoma or ocular hypertension
• Treatment with travoprost or travoprost/timolol

Exclusion Criteria

• High risk of side effects expected from travoprost or travoprost/timolol
• Absolute inability to administer eye drops
• Difficulty in reading or speaking Dutch

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
Intraocular pressure	6 months

Secondary Outcome Measures

Name	Time	Method
Information with regard to the use of eye drops from data generated by the TravAlert dosing system	6 months

Trial Locations

Locations (14)

Medisch centrum Alkmaar; 🇳🇱 Alkmaar, Netherlands

Wilhelmina ziekenhuis; 🇳🇱 Assen, Netherlands

Amphia ziekenhuis; 🇳🇱 Breda, Netherlands

Jeroen Bosch ziekenhuis; 🇳🇱 den Bosch, Netherlands

Deventer ziekenhuis; 🇳🇱 Deventer, Netherlands

Catharina ziekenhuis; 🇳🇱 Eindhoven, Netherlands

Groene hart ziekenhuis; 🇳🇱 Gouda, Netherlands

ziekenhuis de Tjongerschans; 🇳🇱 Heerenveen, Netherlands

Atrium medisch centrum; 🇳🇱 Heerlen, Netherlands

Westfries gasthuis; 🇳🇱 Hoorn, Netherlands

Scroll for more (4 remaining)